JAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)

Affiliation auteurs!!!! Error affiliation !!!!
TitreJAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)
Type de publicationJournal Article
Year of Publication2017
AuteursReck M., Yang C-H., Postmus P.E, Barlesi F., Font E.F, Thomas M., Kim T.M, M. Dols C, Skuladottir H., Park K., Sullivan R., Veatch A.L, Pavlakis N., Dreosti L.M, Ozguroglu M., Morgillo F., Schlichting M., Teofilovici F., Chand V., Westeel V.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534